A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/1999
08/25/1999	EP0936866A1 Compounds, compositions and methods for treating antibiotic-resistant infections
08/25/1999	EP0661967B1 Combined virustatic antimediator (covam) treatment of common colds
08/25/1999	CN1226927A Preparation of ionically cross-linked polyphosphazene microspheres by coacervation
08/25/1999	CN1226829A Method for treating gastrointestinal damage
08/24/1999	US5942663 Transformed biological protein
08/24/1999	US5942619 Quinoline-4-one derivatives with optional alkyl groups at positions 1 and 3, 2-substituted with a branched unsaturated alkyl optionally substituted with hydroxyl or ether; treating ulcers; biosynthesis
08/24/1999	US5942547 2-Deoxystreptamine derivatives, pharmaceutical compositions thereof and therapeutic methods using same
08/24/1999	US5942540 Methods of providing symptomatic and prophylactic neuroprotection
08/24/1999	US5942522 1-benzyl-3-ethoxycarbonyl-4-dimethylaminoethoxy-6-methyl-2-(1h) -quinolinone; antiviral against dna containing viruses, such as herpes group viruses
08/24/1999	US5942512 Method and composition for treating erectile dysfunction
08/24/1999	US5942504 Amine derivatives of oxo- and hydroxy- substituted hydrocarbons
08/24/1999	US5942416 Treatment of infections from bacteria using polypeptides and polynucleotides
08/24/1999	US5942401 An in vitro assay detecting the presence of cytotoxic t-cell response to rev and or tat proteins
08/24/1999	US5942243 Mucoadhesive compositions for administration of biologically active agents to animal tissue
08/24/1999	US5942236 Potential vaccine for use against lyme disease to induce a protective immune response in humans by administrating a purified immunogenic outer surface lipoprotein of micelle form
08/24/1999	US5942234 Hepatitis C virus asialoglycoproteins
08/24/1999	US5942218 A solution comprising polyhexamethylene biguanide; wound treatment material for both prophylaxis and treatment of infections such as an antimicrobial, antiviral, anti-parasitic material
08/24/1999	CA2248972A1 Novel compounds
08/24/1999	CA2176974C Phenyl heterocycles as cyclooxygenase-2 inhibitors
08/24/1999	CA2082044C Modulation of gene expression through interference with rna secondary structure
08/20/1999	CA2249653A1 Novel compounds
08/19/1999	WO1999041404A2 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs
08/19/1999	WO1999041402A2 Targeting of genetic vaccine vectors
08/19/1999	WO1999041397A1 Anti-viral vectors
08/19/1999	WO1999041376A2 Retinoblastoma protein complexes and retinoblastoma interacting proteins
08/19/1999	WO1999041369A2 Genetic vaccine vector engineering
08/19/1999	WO1999041368A2 Optimization of immunomodulatory properties of genetic vaccines
08/19/1999	WO1999041286A1 DERIVATISED ANTIBODIES WITH EXPOSED CARBOHYDRATE CHAINS CAPABLE OF BINDING TO IMMOBILISED IgG
08/19/1999	WO1999041285A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands
08/19/1999	WO1999041283A1 Pf4 fragments and pharmaceutical compositions containing same
08/19/1999	WO1999041268A1 Nucleosides
08/19/1999	WO1999041253A1 Anti-viral pyrimidine derivatives
08/19/1999	WO1999041246A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
08/19/1999	WO1999041244A1 Substituted aminophenyl isoxazoline derivatives useful as antimicrobials
08/19/1999	WO1999041241A1 Heterocyclic topoisomerase poisons
08/19/1999	WO1999041224A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
08/19/1999	WO1999040938A2 Vaccines comprising interleukin-12 and herpes simplex viral antigen
08/19/1999	WO1999040937A2 Vaccines comprising interleukin-12 and respiratory syncytial viral antigens
08/19/1999	WO1999040936A2 Pneumococcal and meningococcal vaccines formulated with interleukin-12
08/19/1999	WO1999040934A1 Strategically modified hepatitis b core proteins and their derivatives
08/19/1999	WO1999040921A2 Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors
08/19/1999	WO1999040916A1 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
08/19/1999	WO1999031250A3 Constitutive expression of non-infectious hiv-like particles
08/19/1999	WO1999030670A3 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
08/19/1999	WO1999029662A3 Urethanes, thio and dithio analogues, the salts thereof, medicaments containing said compounds, use and method for the production thereof
08/19/1999	WO1999001416A3 1-amino-alkylcyclohexane nmda receptor antagonists
08/19/1999	WO1998020095A3 Washing disinfectant for hygienic and surgical hand disinfection
08/19/1999	CA2321277A1 Derivatised antibodies with exposed carbohydrate chains capable of binding to immobilised igg
08/19/1999	CA2321153A1 Anti-viral pyrimidine derivatives
08/19/1999	CA2321136A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands
08/19/1999	CA2321097A1 Anti-viral vectors
08/19/1999	CA2320960A1 Optimization of immunomodulatory properties of genetic vaccines
08/19/1999	CA2320626A1 Genetic vaccine vector engineering
08/19/1999	CA2320431A1 Targeting of genetic vaccine vectors
08/19/1999	CA2320223A1 Pneumococcal and meningococcal vaccines formulated with interleukin-12
08/19/1999	CA2320042A1 Vaccines comprising interleukin-12 and respiratory syncytial viral antigens
08/19/1999	CA2320041A1 Vaccines comprising interleukin-12 and herpes simplex viral antigen
08/19/1999	CA2319782A1 Retinoblastoma protein complexes and retinoblastoma interacting proteins
08/19/1999	CA2319173A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
08/19/1999	CA2319134A1 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs
08/19/1999	CA2318975A1 Prodrugs of 2'3'-dideoxy-3'-fluoro guanosine
08/19/1999	CA2318966A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
08/19/1999	CA2318347A1 Heterocyclic topoisomerase poisons
08/19/1999	CA2315735A1 Substituted aminophenyl isoxazoline derivatives useful as antimicrobials
08/18/1999	EP0935960A1 Use of 1,2-pentanediol in cosmetic or dermatologic composition containing an aqueous dispersion of polymeric film forming particles and cosmetic or dermatologic composition containing these components
08/18/1999	EP0935664A2 New systems for regulating genetic expression
08/18/1999	EP0935663A2 Multi-functional chimeric hematopoietic receptor agonists
08/18/1999	EP0935659A1 Compositions and methods for treating intracellular diseases
08/18/1999	EP0935608A1 Cytotoxic peptides
08/18/1999	EP0935602A1 Pyrido (3,2,1-ij)-1,3,4-benzoxadiazine
08/18/1999	EP0935597A2 Dihydropyrones with improved antiviral activity
08/18/1999	EP0935467A1 Compounds that inhibit interaction between signal-transducing proteins and the glgf (pdz/dhr) domain and uses thereof
08/18/1999	EP0935465A1 Novel substituted imidazole compounds
08/18/1999	EP0935464A1 Inhibitors of farnesyl-protein transferase
08/18/1999	EP0935462A1 Photopheresis treatment of leukocytes
08/18/1999	EP0935461A1 Use of adamantane amines or structurally similar compounds for combating borna disease virus and for the prevention and treatment of affective diseases and other disorders associated with bdv infections in humans and animals
08/18/1999	EP0935458A1 Compositions containing at least one nucleic acid
08/18/1999	EP0935417A1 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
08/18/1999	EP0935415A1 Methods for delivering compounds into a cell
08/18/1999	EP0789715A4 Complementarily bonded two- and three-dimensional supramolecular structures
08/18/1999	EP0703925B1 Production of antibody fragments
08/18/1999	EP0666843B1 Sulfonylalkanoylamino hydroxyethylamino sulfamic acids useful as retroviral protease inhibitors
08/18/1999	EP0652895B1 Compounds which inhibit hiv replication
08/18/1999	EP0479822B1 Therapeutic nucleosides
08/18/1999	CN1226252A Noval erythromycin derivative, method for preparing and use thereof as drugs
08/18/1999	CN1226232A Acryloyl substituted distamycin derivative, process for preparing them, and use as antitumor and antiviral agents
08/18/1999	CN1226171A Type-2 chemokine binding proteins and methods of use thereof
08/18/1999	CN1225945A DNA encoding neospora dihydrofolate reductase-thymidylate synthase
08/18/1999	CN1044707C Substituted aminoalkylaminopyridine, preparation method, its use and medicinal composition containing same compound
08/17/1999	US5939560 Inhibitors of DP-mediated processes, compositions and therapeutic methods thereof
08/17/1999	US5939555 Polymorphs B and C of 1- 2,4-dichloro-β- (7-chlorobenzo b!thien-3-yl)methoxy!phenethyl!imidazole mononitrate
08/17/1999	US5939523 Purification of dalbaheptide antibiotics by isoelectric focusing
08/17/1999	US5939440 Fungicides and bactericides
08/17/1999	US5939434 Tetrazolyl-substituted quinuclidines as substance P antagonists
08/17/1999	US5939415 A!-annellated pyrrole derivatives and their use in pharmacology
08/17/1999	US5939410 1-carba-(dethia)-cephalosporin derivatives
08/17/1999	US5939402 Treating plasmodium, viral infections or parasites in mammals
08/17/1999	US5939399 Polyene antibiotics, 3874 H1 to H6, processes for their preparation and use
08/17/1999	US5939391 Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
08/17/1999	US5939384 Antibiotics as antifungal compounds and antiprotozoa agents

1 ... 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 ... 1798